Retour
Fourchette du Jour
18,49 €
19,43 €
Fourchette 52 Semaines
17,15 €
42,50 €
Volume
3 140 913
Moyenne 50J / 200J
21,91 €
/
27,71 €
Clôture Précédente
19,26 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -10,1 | 0,3 |
| P/B | 9,4 | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -66,3 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Hold
31,33 €
+62.8%
Low: 26,00 €
High: 38,00 €
P/E Prévisionnel
109,4
BPA Prévisionnel
0,18 €
Croissance BPA (est.)
+0,0%
CA Est.
1 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,16 €
1,14 € – 1,18 €
|
1,8 B | 2 |
| FY2029 |
1,07 €
1,05 € – 1,09 €
|
1,7 B | 4 |
| FY2028 |
0,71 €
0,44 € – 0,97 €
|
1,4 B | 6 |
Points Clés
Generating 66,90M in free cash flow
Capital efficient — spends only 2,00% of revenue on capex
ROIC of 3,54% — low return on invested capital
Interest coverage of 0,79× — tight debt servicing
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)96,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC3,54%
Net Margin-66,25%
Op. Margin5,56%
Sécurité
Debt / Equity
0,66
Current Ratio7,85
Interest Coverage0,79
Valorisation
P/E Ratio
-10,11
P/B Ratio9,42
EV/EBITDA111,23
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 96,97% | Revenue Growth (3Y) | 62,87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 812,03M | Net Income (TTM) | -537,96M |
| ROE | N/A | ROA | -47,79% |
| Gross Margin | 66,40% | Operating Margin | 5,56% |
| Net Margin | -66,25% | Free Cash Flow (TTM) | 66,90M |
| ROIC | 3,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,66 | Current Ratio | 7,85 |
| Interest Coverage | 0,79 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,11 | P/B Ratio | 9,42 |
| P/S Ratio | 6,70 | PEG Ratio | 2,83 |
| EV/EBITDA | 111,23 | Dividend Yield | 0,00% |
| Market Cap | 5,44B | Enterprise Value | 5,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 812,03M | 412,26M | 306,13M | 258,49M | 294,01M |
| Net Income | -537,96M | -281,89M | -341,42M | -320,83M | 27,73M |
| EPS (Diluted) | -1,90 | -2,70 | -1,82 | -1,57 | 1,55 |
| Gross Profit | 539,17M | 178,78M | 89,31M | 80,02M | 184,16M |
| Operating Income | 45,11M | -257,12M | -319,55M | -315,76M | 139,09M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1,13B | 343,73M | 412,90M | 717,42M | 2,61B |
| Total Liabilities | 548,36M | 2,84B | 2,56B | 2,42B | 1,91B |
| Shareholders' Equity | 577,31M | -2,50B | -2,14B | -1,70B | 702,24M |
| Total Debt | 378,99M | 424,26M | 217,27M | 270,87M | 1,75B |
| Cash & Equivalents | 797,80M | 63,95M | 56,40M | 107,19M | 53,55M |
| Current Assets | 997,80M | 215,73M | 242,61M | 516,04M | 214,66M |
| Current Liabilities | 127,15M | 165,42M | 95,14M | 136,91M | 320,25M |